Stay updated on Pembrolizumab Combo in Premenopausal HR+/HER2- Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Premenopausal HR+/HER2- Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Premenopausal HR+/HER2- Breast Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Locations section expanded with numerous sites across US states and international regions, detailing where the trial is conducted.
    Difference
    2%
    Check dated 2025-12-19T07:32:00.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    The page shows a minor revision label update from v3.3.1 to v3.3.2. This change does not affect content or functionality of the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-28T00:31:15.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Publications section now notes that items are auto-filled from PubMed and may not relate to the study, and includes a Revision: v3.3.1.
    Difference
    0.2%
    Check dated 2025-11-20T22:37:17.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    Removed the government funding operating status notice from the page. The notice was a general site-wide status message, not specific to the MIRASOL trial details.
    Difference
    0.1%
    Check dated 2025-11-13T17:04:45.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    A recent update shows only timestamp changes and minor text refinements; core study details, eligibility criteria, interventions, outcomes, and locations remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-10-30T11:24:45.000Z thumbnail image
  9. Check
    99 days ago
    Change Detected
    Summary
    - Updated revision from v3.0.2 to v3.2.0. This indicates a new version release, but does not imply other changes to content.
    Difference
    0.0%
    Check dated 2025-10-01T05:35:35.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Premenopausal HR+/HER2- Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Premenopausal HR+/HER2- Breast Cancer Clinical Trial page.